Evidence map›Paper›PMID 36520244›Full record

ArticleCancer causes & control : CCC2023

Survival of epithelial ovarian cancer in Black women: a society to cell approach in the African American cancer epidemiology study (AACES).

Joellen M Schildkraut, Courtney Johnson, Lauren F Dempsey, Bo Qin, Paul Terry, Maxwell Akonde, Edward S Peters, Hannah Mandle, Michele L Cote, Lauren Peres and 8 more

Abstract read
In one paragraph

Article in Cancer causes & control : CCC, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Homologous Recombination Deficiency and Survival in Ovarian High-Grade Serous Carcinoma by Self-Reported Race.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  7. Article
  8. An Analytic Pipeline to Obtain Reliable Genetic Ancestry Estimates from Tumor-Derived RNA Sequencing Data.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Molecular Subtypes of High-Grade Serous Ovarian Cancer across Racial Groups and Gene Expression Platforms.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Joellen M SchildkrautDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA. joellen.m.schildkraut@emory.edu.
Courtney JohnsonDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Lauren F DempseyDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Bo QinCancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Paul TerryDepartment of Medicine, University of Tennessee Medical Center-Knoxville, Knoxville, TN, USA.
Maxwell AkondeDepartment of Medicine, University of Tennessee Medical Center-Knoxville, Knoxville, TN, USA.
Edward S PetersDepartment of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA.
Hannah MandleDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Michele L CoteIndiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN, USA.
Lauren PeresDepartment of Cancer Epidemiology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, USA.
Patricia MoormanDepartment of Family Medicine and Community Health, Duke University School of Medicine, Durham, NC, USA.
Ann G SchwartzDepartment of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.
Michael EpsteinDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Jeffrey MarksDepartment of Surgery, Duke University School of Medicine, Durham, NC, USA.
Melissa BondyDepartment of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA.
Andrew B LawsonDepartment of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, SC, USA.
Anthony J AlbergDepartment of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
Elisa V BanderaCancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI Christine O'Connell · 1998 to 2026
$93.5M
Epidemiology of Ovarian Cancer in African-American WomenR01CA142081 · NCI · UNIVERSITY OF VIRGINIA · PI SCHILDKRAUT, JOELLEN M. · 2010 to 2015
$10.6M
Ovarian Cancer Survival in African-American WomenR01CA237318 · NCI · EMORY UNIVERSITY · PI LAWSON, ANDREW B., SCHILDKRAUT, JOELLEN M. · 2020 to 2024
$5.9M
NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA142081NCI NIH HHS R01CA142081, R01CA237318NCI NIH HHS R01 CA237318
6 · The paper itself

Abstract

purposeThe causes for the survival disparity among Black women with epithelial ovarian cancer (EOC) are likely multi-factorial. Here we describe the African American Cancer Epidemiology Study (AACES), the largest cohort of Black women with EOC.

methodsAACES phase 2 (enrolled 2020 onward) is a multi-site, population-based study focused on overall survival (OS) of EOC. Rapid case ascertainment is used in ongoing patient recruitment in eight U.S. states, both northern and southern. Data collection is composed of a survey, biospecimens, and medical record abstraction. Results characterizing the survival experience of the phase 1 study population (enrolled 2010-2015) are presented.

resultsThus far, ~ 650 patients with EOC have been enrolled in the AACES. The five-year OS of AACES participants approximates those of Black women in the Surveillance Epidemiology and End Results (SEER) registry who survive at least 10-month past diagnosis and is worse compared to white women in SEER, 49 vs. 60%, respectively. A high proportion of women in AACES have low levels of household income (45% < $25,000 annually), education (51% ≤ high school education), and insurance coverage (32% uninsured or Medicaid). Those followed annually differ from those without follow-up with higher levels of localized disease (28 vs 24%) and higher levels of optimal debulking status (73 vs 67%).

conclusionAACES is well positioned to evaluate the contribution of social determinants of health to the poor survival of Black women with EOC and advance understanding of the multi-factorial causes of the ovarian cancer survival disparity in Black women.

Indexed as

Black or African AmericanCarcinoma, Ovarian EpithelialOvarian NeoplasmsFemaleHumansRegistriesUnited StatesCancer survivorsEpithelial ovarian cancerRacial disparitiesSocial determinants of health

Identifiers

PMID36520244
PMCPMC9753020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.